Thanks for the contributions and positive feedback all - Have to say added much value to my day, if only for the additional interaction to alleviate some of the isolation us home investors accept as part of what we do.

So, here we go with Day 2, all being well will be back tomorrow.

Interserve (IRV)Half Year Results To June 2017 – This is a perfect example of an update I just avoid, it’s just a mess to me. Revenue pretty much unchanged, Profits and EPS substantially increased (from a reasonable LFL loss to a now reasonable LFL profit). On the look of it it’s a great improvement, one for the more experienced investor though, not me!  (Stockopedia flags it as a Value Trap – Down 50% from 12 month high)

Lok’n Store (LOK)Pre Close Trading Statement – Revenues/Occupancy up about 6% LFL (classed as “excellent”!) – On target to add 26% more capacity by end 2018 – On a PER of 24 not sure there’s much to excite here!

Quantum Pharma (QP.)Half Year Trading Update – It’s losing money and has debt – Would have liked this report to refer to, in some way, the fact it is projected to be profitable next year. Not sure how the market will take this update but it doesn’t interest me.

SCS (SCS)Trading Update – In line with expectations, overall order growth of 1.4%. Seems strange to be mentioning 2 year LFL as it’s better than the 1 year. Seems steady enough and Stockpedia likes it, and why not, a Speculative Super Stock with a Stock Rank of 96. A PER of about 7, ROCE 30%+, a stonking 9% Dividend (reasonably covered) and about 50% Mkt Cap of cash! Most recent SCVR update (and additional member comment) here raises some red flags – Mainly related to the value of the cash, the quality of the products, the fact it may be paying too much in dividends instead of preparing for a potential downturn (bolstering the books) – Suppose in line with the update mentioned above, timing is probably everything here.

Share (SHRE)Half Year Results To June 2017 – Results ahead of management expectations and outperformance against it’s peers. But profit wise, cannot…

Unlock the rest of this article with a 14 day trial

or Unlock with your email

Already have an account?
Login here